Besides, GPR183 was another critical gene, which tended to be upregulated in PCa patients with a better prognosis (Figure 3E), but the difference in the GPR183 expression levels between PCa and normal control patients was not statistically significant (P=0.062). The gene discussed is GPR183; the disease is posterior cortical atrophy.